Why Upstart Stock Is Down More Than 13% Today

Upstart reported fiscal‑2025 Q4 revenue of $265 million, up 35% year‑over‑year, and swung to a profit of $18.6 million while loan originations rose 86%; despite a revenue beat on several measures the stock fell roughly 13.5% intraday largely after missing some estimates and announcing the impending departure of CEO Dave Girouard (to be replaced by co‑founder/CTO Paul Gu in May). Management will stop providing quarterly guidance and move to full‑year outlooks while publishing monthly loan‑origination metrics; the company projects roughly $1.4 billion in 2026 sales (vs. $1.0 billion prior) and maintains a 35% annualized revenue growth target through 2028, with analysts forecasting acceleration from ~24.6% in 2026 to ~34% in 2027.

Analysis

Market structure: Upstart’s 13%+ sell-off disproportionately hurts sentiment-driven fintech beta while directly benefiting buyers of idiosyncratic, AI-led credit exposure who can scale into a stock that still projects ~35% CAGR through 2028 and reported loan originations +86% YoY. The decision to stop quarterly guidance shifts informational advantage toward investors who can parse monthly origination KPIs; expect higher realized volatility and wider bid/ask in the near term as liquidity-seeking algos reprice position sizes.

Risk assessment: Primary tail risks are regulatory scrutiny of algorithmic credit (rule changes within 6–18 months), a botched CEO transition in May that delays product roadmaps, and macro-driven credit deterioration—> a 10–15ppt rise in 30+ day delinquencies would likely erase FY profitability. Immediate (days) risk = elevated IV and flow volatility; short-term (weeks/months) = management/guide noise; long-term = credit-cycle and model-validation risk tied to partner banks and warehouse financing.

Trade implications: Favor asymmetric exposure—buy optionality on UPST while protecting downside. Implement 12–18 month call spreads (LEAPs) funded by selling OTM calls, and use 45–90 day put spreads to hedge through the CEO transition and next monthly KPIs. Consider pair trades that long UPST vs short structurally weaker fintechs (e.g., AFRM) to neutralize systemic fintech beta.

Contrarian angles: Consensus is fixated on guidance cadence and CEO optics; it misses that Upstart will publish monthly origination metrics and still targets high-teens/30s revenue growth—this makes the sell-off likely overdone absent credit deterioration. Historical parallels (tech names hit by founder exits) show 3–12 month mean reversion when fundamentals hold; key unintended consequence: reduced cadence may force the company to over-index monthly KPIs, improving signal quality for active investors.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in UPST within 2–6 weeks, scaling in on any additional 10–20% downside; set a hard stop at -30% from average cost and target 40–60% upside within 9–18 months if monthly origination growth >50% YoY and full-year guidance is maintained.
• Buy a 12–18 month (Jan 2027) call spread on UPST sized to 0.5–1% of portfolio (buy near-ATM LEAP, sell 1.5x OTM) to capture asymmetric upside while limiting premium outlay; simultaneously buy a 45–90 day put spread (cost <0.5% portfolio) to hedge CEO-transition volatility and next two monthly KPI releases.
• Implement a pair trade: long UPST (1–2% notional) vs short AFRM (1% notional) to isolate Upstart-specific fundamentals; unwind the pair if UPST outperforms AFRM by >20% in 60 days or if UPST revises FY revenue guidance down >5%.
• Reduce exposure to legacy credit-data and credit-sensitive regional bank names by 1–2% of portfolio over the next month and redeploy into AI/fintech enablers (UPST and selective AI exposure like NVDA) to capture secular AI-in-credit adoption while limiting cyclical credit risk.